Abstract:The aim of study was to discuss the correlation and regulatory mechanism of HIF-1 and miR-191 expression in pancreatic tumor. The association between the miR-191 and the clinicopathologic characteristics and the prognosis of pancreatic cancer was further explored. After hypoxic cultured for 6 and 12 h, qRT-PCR and Western blot were practiced to analyze the miR-191 and HIF-1 expression of MIA PaCa-2 and Aspac1 cells. We regulated the HIF-1 expression via plasmid and siRNA transfection to observe the alteration of HIF-1 and miR-191 expression. ChIP sequencing identified the binding sites of HIF-1 and miR-191. Dual luciferase assays were practiced to verify the binding sites. Immunohistochemical staining was practiced to analyze the expression of HIF-1, while qRT-PCR were done for investigating miR-191 in tumor tissues. Then, the association between the expression of them and the clinicopathologic characteristics and prognosis of pancreatic cancer were analyzed. After hypoxic cultured 12 h, the expression of HIF-1 protein, HIF-1mRNA and miR-191 of MIA PaCa-2 and AsPC-1 cells increased significantly (P < 0.05). After HIF-1 overexpressing plasmid transfected to the MIA PaCa-2 and AsPC-1 cells for 48 h, the expression of HIF-1 protein, HIF-1mRNA, and miR-191 upregulated significantly (P < 0.05). While after transfected the MIA PaCa-2 cells by HIF-1 siRNA, the significant decreasing of HIF-1 protein, HIF-1mRNA, and miR-191 expression were observed (P < 0.05). ChIP sequencing showed the protein synthesis of HIF-1 increased in hypoxia situation. Only the HRE5 (-1,169 bp, ChIP4) were significantly brighter in hypoxia in comparing with normoxic cells. In dual luciferase assays, after pGL3-miR-191 and HIF-1 overexpressing plasmid co-transfect the MIAPaCa-2 cells for 48 h, its relative expression of bioluminescence was higher than those co-transfected by mutant miR-191 vectors and HIF-1 overexpressing plasmid or by pGL3-miR-191 and HIF-1 empty plasmid. The expression of miR-191 closely associated with the tumor size, pTNM stage, lymph node metastasis, and perineural invasion (P < 0.05). Patients with higher expression of miR-191 were a risk factor for prognosis of pancreatic cancers. Expression of HIF-1 in pancreatic cancer cells increased under the condition of chronic hypoxia, which may bind to HRE2 in 5'flanking region of miR-191 and initiate transcription of miR-191. Expression of miR-191 was significantly higher in pancreatic tumor tissues. The expression of miR-191 closely associated with the tumor size, pTNM stage, lymph node metastasis and perineural invasion and poor prognosis of pancreatic cancer.

Overexpressions of Mir-212 Are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma

Mir-186 And 326 Predict The Prognosis Of Pancreatic Ductal Adenocarcinoma And Affect The Proliferation And Migration Of Cancer Cells

The Clinical Significance of miR-34a in Pancreatic Ductal Carcinoma and Associated Molecular and Cellular Mechanisms.

Overexpressions of DLL4 and CD105 Are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma

Mir-371-5p Facilitates Pancreatic Cancer Cell Proliferation and Decreases Patient Survival

Low Serum Mir-607 Level As a Potential Diagnostic and Prognostic Biomarker in Patients of Pancreatic Ductal Adenocarcinoma: A Preliminary Study.

Dysregulation of Mir-15A and Mir-214 in Human Pancreatic Cancer

Elevated expression of tumor miR-222 in pancreatic cancer is associated with Ki67 and poor prognosis

Identification of biomarkers for the prognosis of pancreatic ductal adenocarcinoma with miRNA microarray data

Mir-212 Promotes Pancreatic Cancer Cell Growth and Invasion by Targeting the Hedgehog Signaling Pathway Receptor Patched-1

MicroRNA-506 is Up-Regulated in the Development of Pancreatic Ductal Adenocarcinoma and is Associated with Attenuated Disease Progression

Down-regulation of miR-539 indicates poor prognosis in patients with pancreatic cancer

Microrna-218: A Potential Regulator of Lymphatic Metastasis in Pancreatic Ductal Adenocarcinoma

Potential Four‑mirna Signature Associated with Tstage and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma Identified by Co‑expression Analysis

The Clinical Significance and Regulation Mechanism of Hypoxia-Inducible Factor-1 and Mir-191 Expression in Pancreatic Cancer.

Overexpression of Mir-135b-5p Promotes Unfavorable Clinical Characteristics and Poor Prognosis Via the Repression of Sfrp4 in Pancreatic Cancer

MicroRNA Profiles in Pancreatic Ductal Adenocarcinoma

Effect of Mir-184 on Proliferation and Apoptosis of Pancreatic Ductal Adenocarcinoma and Its Mechanism

Increased Levels of miR-15b-5p and miR-20b-5p in Pancreatic Ductal Adenocarcinoma with Hepatic Metastases

Association of microRNA-23 b-3 p down-regulation with progression and survival in pancreatic duct adenocarcinoma and its prospective function via bioinformatics analysis

Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance